Akcea Therapeutics

YTD

ALL

Why Robinhood?

You can watch AKCA and buy or sell other stocks, ETFs, and their options commission-free!

About AKCA

Akcea Therapeutics is a development and commercialization company focused on helping patients with serious diseases. Our priority is to drive clinical program execution, understand patient and physician needs, prepare the market, create market access, and commercialize our products on a global basis.

CEO

Damien McDevitt, PhD

CEODamien McDevitt, PhD

Employees

—

Employees—

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2014

Founded2014

Employees

—

Employees—

AKCA Key Statistics

Market cap

1.85B

Market cap1.85B

Price-Earnings ratio

-46.08

Price-Earnings ratio-46.08

Dividend yield

—

Dividend yield—

Average volume

476.70K

Average volume476.70K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$21.71

52 Week high$21.71

52 Week low

$8.00

52 Week low$8.00

People also own

Based on the portfolios of people who own AKCA. This list is generated using Robinhood data, and it’s not a recommendation.